What does APOTHEEK SMET & VAN ASSCHE do?

APOTHEEK SMET & VAN ASSCHE is a pharmacy in Antwerpen. Private Limited, started on 1 December 1989, 1 establishment.

What is the address of APOTHEEK SMET & VAN ASSCHE?

The registered office of APOTHEEK SMET & VAN ASSCHE is located at Drakenhoflaan 60, 2100 Antwerpen.

Is APOTHEEK SMET & VAN ASSCHE still active?

Yes. According to the CBE (31 October 2026) APOTHEEK SMET & VAN ASSCHE is active, legal situation “Normale toestand”, started on 1 December 1989.

Is APOTHEEK SMET & VAN ASSCHE registered on Peppol?

Yes, APOTHEEK SMET & VAN ASSCHE is registered on the Peppol network with ID 0208:0438976765.

What is the enterprise number of APOTHEEK SMET & VAN ASSCHE?

The enterprise number of APOTHEEK SMET & VAN ASSCHE is BE0438976765.

When was APOTHEEK SMET & VAN ASSCHE founded?

APOTHEEK SMET & VAN ASSCHE was founded on 1 December 1989.

Who are the directors of APOTHEEK SMET & VAN ASSCHE?

According to the 2025 annual accounts, the directors of APOTHEEK SMET & VAN ASSCHE are: Sofie Smet, Carolien Van Assche.

Is APOTHEEK SMET & VAN ASSCHE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 1989; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK SMET & VAN ASSCHE make in 2025?

APOTHEEK SMET & VAN ASSCHE posted a profit after taxes of € 10,521 in financial year 2025.

What is the revenue of APOTHEEK SMET & VAN ASSCHE?

As a small company, APOTHEEK SMET & VAN ASSCHE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 193,607.

Does APOTHEEK SMET & VAN ASSCHE have a website?

Yes, APOTHEEK SMET & VAN ASSCHE has a website at apotheeksmet.be.

APOTHEEK SMET & VAN ASSCHE (Private Limited) - Antwerpen

Dossier APOTHEEK SMET & VAN ASSCHE, printed on 1 November 2026 from databakkes.be/en/0438976765/apotheek-smet-van-assche. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK SMET & VAN ASSCHE from Antwerpen, company number BE0438976765, closed financial year 2025 with a result of € 10,521 after tax. For that financial year APOTHEEK SMET & VAN ASSCHE recorded a gross margin of € 193,607 and equity of € 258,741. Compared with financial year 2024, the result moved from € -12,849 to € 10,521. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2026.

What it is worth Growing

€ 258,741

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 10,521

▲ still € 12,849 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 18,505

▲ 111% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 240,149.

People and assets in 2025

Wage cost

€ 169,530

▲ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 67,037

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 23,302

▲ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 184,596 Gross margin 2022: € 184,596 First fiscal year in the series	€ 191,440 Gross margin 2023: € 191,440 ▲ 4% vs 2022 (€ 184,596) Favourable step	€ 158,147 Gross margin 2024: € 158,147 ▼ 17% vs 2023 (€ 191,440) Unfavourable step	€ 193,607 Gross margin 2025: € 193,607 ▲ 22% vs 2024 (€ 158,147) Favourable step	▲ 22%
Profit after taxes	€ 27,205 Profit after taxes 2022: € 27,205 First fiscal year in the series	€ 21,782 Profit after taxes 2023: € 21,782 ▼ 20% vs 2022 (€ 27,205) Unfavourable step	€ -12,849 Profit after taxes 2024: € -12,849 ▼ € 34,631 vs 2023 (€ 21,782) Unfavourable step	€ 10,521 Profit after taxes 2025: € 10,521 ▲ € 23,370 vs 2024 (€ -12,849) Favourable step	▲ € 23,370
Equity	€ 252,298 Equity 2022: € 252,298 First fiscal year in the series	€ 262,360 Equity 2023: € 262,360 ▲ 4% vs 2022 (€ 252,298) Favourable step	€ 249,511 Equity 2024: € 249,511 ▼ 5% vs 2023 (€ 262,360) Unfavourable step	€ 258,741 Equity 2025: € 258,741 ▲ 4% vs 2024 (€ 249,511) Favourable step	▲ 4%
Total debts	€ 96,685 Total debts 2022: € 96,685 First fiscal year in the series	€ 122,584 Total debts 2023: € 122,584 ▲ 27% vs 2022 (€ 96,685) Unfavourable step	€ 107,854 Total debts 2024: € 107,854 ▼ 12% vs 2023 (€ 122,584) Favourable step	€ 110,445 Total debts 2025: € 110,445 ▲ 2% vs 2024 (€ 107,854) Unfavourable step	▲ 2%
Cash	€ 69,840 Cash 2022: € 69,840 First fiscal year in the series	€ 46,709 Cash 2023: € 46,709 ▼ 33% vs 2022 (€ 69,840) Unfavourable step	€ 8,785 Cash 2024: € 8,785 ▼ 81% vs 2023 (€ 46,709) Unfavourable step	€ 18,505 Cash 2025: € 18,505 ▲ 111% vs 2024 (€ 8,785) Favourable step	▲ 111%
Land & buildings	€ 3,450 Land & buildings 2022: € 3,450 First fiscal year in the series	€ 2,199 Land & buildings 2023: € 2,199 ▼ 36% vs 2022 (€ 3,450) Unchanged	€ 1,099 Land & buildings 2024: € 1,099 ▼ 50% vs 2023 (€ 2,199) Unchanged	€ 0 Land & buildings 2025: € 0 ▼ 100% vs 2024 (€ 1,099) Unchanged	▼ 100%
Retained profit	€ 233,706 Retained profit 2022: € 233,706 First fiscal year in the series	€ 243,768 Retained profit 2023: € 243,768 ▲ 4% vs 2022 (€ 233,706) Favourable step	€ 230,919 Retained profit 2024: € 230,919 ▼ 5% vs 2023 (€ 243,768) Unfavourable step	€ 240,149 Retained profit 2025: € 240,149 ▲ 4% vs 2024 (€ 230,919) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 10,000 Dividend 2023: € 10,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 10,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 12,117 Bank debt 2022: € 12,117 First fiscal year in the series	€ 7,137 Bank debt 2023: € 7,137 ▼ 41% vs 2022 (€ 12,117) Favourable step	€ 2,109 Bank debt 2024: € 2,109 ▼ 70% vs 2023 (€ 7,137) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 2,109) Favourable step	▼ 100%
Balance sheet total	€ 348,983 Balance sheet total 2022: € 348,983 First fiscal year in the series	€ 384,944 Balance sheet total 2023: € 384,944 ▲ 10% vs 2022 (€ 348,983) Unchanged	€ 357,365 Balance sheet total 2024: € 357,365 ▼ 7% vs 2023 (€ 384,944) Unchanged	€ 369,186 Balance sheet total 2025: € 369,186 ▲ 3% vs 2024 (€ 357,365) Unchanged	▲ 3%

Key figures of APOTHEEK SMET & VAN ASSCHE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SMET & VAN ASSCHE?

What happened at APOTHEEK SMET & VAN ASSCHE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 11, 2026 New annual accounts for financial year 2025: profit of € 10,521. filed late Source: NBB ↗
2021 Sofie Smet became a director. NBB
2021 Carolien Van Assche became a director. NBB
Dec 19, 1989 New establishment in Antwerpen. KBO
Dec 1, 1989 Start of the company according to the CBE. KBO

In short

From € 27,205 profit in 2022 to € 10,521 profit in 2025.

Paid € 16,348 in corporate taxes since 2022.

Best year ever: 2022, with € 27,205 profit.

Paid out € 10,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Farma&Cie 49.1%

The stake of Farma&Cie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SMET & VAN ASSCHE

Behind APOTHEEK SMET & VAN ASSCHE are Sofie Smet and Carolien Van Assche. The shares are held by Farma&Cie (49.1%).

Directors

According to the 2025 annual accounts

Sofie Smet

Director

since 2021

Carolien Van Assche

Director

Also active at: Farma&Cie, Apotheek Van Assche

since 2021

Shareholders

Farma&Cie

49.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Drakenhoflaan 60

2100 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeksmet.be

About

Technologies

BootstrapCloudflare CDNContact Form 7Font AwesomeGoogle FontsGoogle MapsLightboxOwl CarouselPHPWP RocketWPBakeryWordPressYoast SEOjQuerylazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Client portal Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ Load balancing

Details

Company number

0438.976.765

VAT number

BE 0438.976.765

Registered office

Drakenhoflaan 60, 2100 Antwerpen

Names & denominations

APOTHEEK SMET & VAN ASSCHE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 December 1989

Peppol

Active · Active since 20 Nov 2025

Contact

apotheeksmet.be [email protected] 03/321.13.45

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SMET & VAN ASSCHE

Financials

What happened to APOTHEEK SMET & VAN ASSCHE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions